Search research articles
Contact Us
Filters
Showing results (851-860 of 1,046) with videos related to
Page
of 105
Sort By:
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik
|
May 14, 2004
Use of Pi5(t) markers in marker-assisted selection to screen for cultivars with resistance to Magnaporthe grisea
G Yi, S-K Lee, Y-K Hong, et al.
Frontiers in Genetics
|
November 5, 2019
EBV-miR-BART7-3p Imposes Stemness in Nasopharyngeal Carcinoma Cells by Suppressing SMAD7
Longmei Cai, Yufei Long, Tuotuo Chong, et al.
Biomolecules
|
January 17, 2020
Avocado-Soybean Unsaponifiables: A Panoply of Potentialities to Be Exploited
Bahare Salehi, Antonio Rescigno, Tinuccia Dettori, et al.
Cancer Letters
|
November 29, 2024
Advancements and challenges of R-loops in cancers: Biological insights and future directions
Dengxiong Li, Fanglin Shao, Xinrui Li, et al.
Cancer Research Communications
|
March 13, 2024
Correction: Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study
Pamela Munster, Nicholas Iannotti, Daniel C Cho, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 25, 2009
Retrospective analysis of the safety and efficacy of interleukin-2 after prior VEGF-targeted therapy in patients with advanced renal cell carcinoma
Daniel C Cho, Igor Puzanov, Meredith M Regan, et al.
Apoptosis : an International Journal on Programmed Cell Death
|
June 22, 2025
The role of the NcRNA/ferroptosis axis in lung cancer: molecular mechanisms and potential therapeutic targets
Mina Alimohammadi, Samaneh Kahkesh, William C Cho, et al.
The Journal of Physiology
|
June 28, 2021
β-Catenin is required for optimal exercise- and contraction-stimulated skeletal muscle glucose uptake
Stewart W C Masson, Jonathan S T Woodhead, Randall F D'Souza, et al.
Journal for Immunotherapy of Cancer
|
July 24, 2021
CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study
Rachel E Sanborn, Omid Hamid, Elisabeth Ge de Vries, et al.
Translational Lung Cancer Research
|
December 13, 2024
Analysis of the lymph node metastasis distribution in patients with invasive resectable non-small cell lung cancer
Congcong Xu, Jiajing Sun, Hao Liu, et al.
Page
of 105
Search research articles
Search
Showing results (851-860 of 1,046) with videos related to
Sort By:
Page
of 105
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik
|
May 14, 2004
Use of Pi5(t) markers in marker-assisted selection to screen for cultivars with resistance to Magnaporthe grisea
G Yi, S-K Lee, Y-K Hong, et al.
Frontiers in Genetics
|
November 5, 2019
EBV-miR-BART7-3p Imposes Stemness in Nasopharyngeal Carcinoma Cells by Suppressing SMAD7
Longmei Cai, Yufei Long, Tuotuo Chong, et al.
Biomolecules
|
January 17, 2020
Avocado-Soybean Unsaponifiables: A Panoply of Potentialities to Be Exploited
Bahare Salehi, Antonio Rescigno, Tinuccia Dettori, et al.
Cancer Letters
|
November 29, 2024
Advancements and challenges of R-loops in cancers: Biological insights and future directions
Dengxiong Li, Fanglin Shao, Xinrui Li, et al.
Cancer Research Communications
|
March 13, 2024
Correction: Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study
Pamela Munster, Nicholas Iannotti, Daniel C Cho, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 25, 2009
Retrospective analysis of the safety and efficacy of interleukin-2 after prior VEGF-targeted therapy in patients with advanced renal cell carcinoma
Daniel C Cho, Igor Puzanov, Meredith M Regan, et al.
Apoptosis : an International Journal on Programmed Cell Death
|
June 22, 2025
The role of the NcRNA/ferroptosis axis in lung cancer: molecular mechanisms and potential therapeutic targets
Mina Alimohammadi, Samaneh Kahkesh, William C Cho, et al.
The Journal of Physiology
|
June 28, 2021
β-Catenin is required for optimal exercise- and contraction-stimulated skeletal muscle glucose uptake
Stewart W C Masson, Jonathan S T Woodhead, Randall F D'Souza, et al.
Journal for Immunotherapy of Cancer
|
July 24, 2021
CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study
Rachel E Sanborn, Omid Hamid, Elisabeth Ge de Vries, et al.
Translational Lung Cancer Research
|
December 13, 2024
Analysis of the lymph node metastasis distribution in patients with invasive resectable non-small cell lung cancer
Congcong Xu, Jiajing Sun, Hao Liu, et al.
Page
of 105